Skip to main content

Marina Forms New Early-Stage Collaboration, Issued Notice of Allowance on Peptide Delivery Tech

Premium

Marina Biotech this week announced that it has established an early-stage research collaboration with an undisclosed "major pharmaceutical company" focused on the evaluation of Marina's proprietary amphoteric liposomal formulations for pulmonary delivery.

Additional details about the arrangement were not disclosed.

Marina also said that the Intellectual Property Office of New Zealand has issued a notice of acceptance for a company patent application related to tumor-targeting delivery peptides.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.